RESUMEN
OBJECTIVE: To demonstrate a novel technique used to restore cervical patency in a patient with severe iatrogenic cervical stenosis. DESIGN: Surgical video case report. SETTING: A single academic institution. PATIENT(S): We highlight the case of a 35-year-old nulliparous woman with a history of primary infertility. Her past medical history was significant for focal, invasive, well-differentiated squamous cell carcinoma of the cervix, for which she underwent a loop electrosurgical excision procedure. During her infertility assessment, she was found to have an extremely stenotic cervix that was refractory to conventional treatment options. INTERVENTIONS: This video highlights our innovative laparoscopic transfundal technique used to restore her cervical patency. MAIN OUTCOME MEASURES: None, as this is a descriptive case report. RESULTS: Postoperatively, the patient had continued cervical patency for >1 year with successful fertility treatment resulting in pregnancy. CONCLUSIONS: To our knowledge, this is the first case report describing a laparoscopic transfundal approach used to reestablish cervical patency. This approach may be considered for patients with cervical stenosis who have not responded to standard conservative therapies.
Asunto(s)
Infertilidad Femenina , Laparoscopía , Humanos , Femenino , Laparoscopía/métodos , Adulto , Infertilidad Femenina/cirugía , Infertilidad Femenina/etiología , Infertilidad Femenina/terapia , Infertilidad Femenina/diagnóstico , Embarazo , Cuello del Útero/cirugía , Constricción Patológica/cirugía , Resultado del Tratamiento , Dilatación/métodos , Enfermedades del Cuello del Útero/cirugía , Enfermedades del Cuello del Útero/diagnóstico , Enfermedades del Cuello del Útero/complicaciones , Neoplasias del Cuello Uterino/cirugía , Neoplasias del Cuello Uterino/complicacionesRESUMEN
STUDY OBJECTIVE: To demonstrate our hysteroscopic technique using the mini-resectoscope for the treatment of complete uterine septum with or without cervical anomalies. DESIGN: A step-by-step video demonstration of the technique with the use of an educational video. SETTINGS: We present 3 patients diagnosed as having complete uterine septum (U2b according to the ESHRE/ESGE classification) with or without cervical anomalies (C0, normal cervix; C1, septate cervix; C2, double "normal" cervix"), 2 of them with a longitudinal vaginal septum (V1). The first case is a 33-year-old woman with history of primary infertility diagnosed as having a complete uterine septum with normal cervix (class U2bC0V0 according to the ESHRE/ESGE classification). Case 2 is a 34-year-old woman with infertility and abnormal uterine bleeding, diagnosed as having complete uterine and cervical septum and a partial nonobstructive vaginal septum (class U2bC1V1). Case 3 is a 28-year-old woman with infertility and dyspareunia, diagnosed as having a complete uterine septum, double "normal" cervix, and nonobstructive longitudinal vaginal septum (class U2bC2V1) Still 3. The procedures were performed in a tertiary care university hospital. INTERVENTION: The 3 procedures were performed in the operative room using a 15 Fr continuous flow mini-resectoscope and bipolar energy with the patient under general anesthesia Still 1 and Still 2. No complications were encountered in any of the 3 cases. After all procedures, a gel based on hyaluronic acid was applied to minimize postoperative adhesion formation. Patients were discharged home the same day of the procedure after a short period of observation. CONCLUSION: Hysteroscopic treatment of patients with uterine septa associated or not with cervical anomalies using miniaturized instruments is a feasible and effective option for the management of patients with these complex müllerian anomalies.
Asunto(s)
Infertilidad , Útero Septado , Enfermedades del Cuello del Útero , Embarazo , Femenino , Humanos , Adulto , Histeroscopía/métodos , Útero/cirugía , Útero/anomalías , Enfermedades del Cuello del Útero/complicaciones , Enfermedades del Cuello del Útero/cirugíaRESUMEN
In rare cases, cervical ectropion causes symptoms such as abundant leucorrhoea, postcoital bleeding, recurrent cervicitis, pelvic pain, and dyspareunia. Cryotherapy is a commonly used treatment for symptomatic cervical ectropion. We assessed the impact of cryotherapy on sexual function and quality of life among patients with symptomatic cervical ectropion. In this prospective observational study, 73 patients were assessed before and six months after cryotherapy treatment using the Female Sexual Function Index (FSFI) and Short Form-12 Health Survey questionnaires. The double-freeze cryotherapy procedure was performed using a cryotherapy unit, and liquid nitrogen was used as a refrigerant. The mean physical and mental quality of life scores were significantly improved after treatment. With the exception of the pain domain, the overall and domain FSFI scores exhibited no significant differences before and after cryotherapy. The sexual pain domain scores were significantly increased after treatment. There was a statistically significant improvement in vaginal discharge, pelvic pain, and postcoital bleeding symptoms after the cryotherapy. We concluded that cryotherapy is an effective and feasible treatment for symptomatic cervical ectropion. Although cryotherapy results in improved quality of life scores, it has no significant impact on female sexual function.Impact statementWhat is already known on this subject? Cryotherapy is the most preferred treatment option for symptomatic cervical ectropion. Its feasibility and effectiveness with respect to symptom relief have been observed in previous studies. No study has evaluated quality of life and sexual function after cryotherapy among patients with symptomatic cervical ectropion.What do the results of this study add? Although the patients' quality of life scores were significantly improved after treatment, no significant improvement was observed in overall and domain sexual function scores, with the exception of the pain domain. The sexual pain domain scores were significantly improved after cryotherapy.What are the implications of these findings for clinical practice and/or further research? Patients should not expect better sexual function after cryotherapy. Comparative studies should seek to identify the ideal treatment option, which would result in both symptom relief and better sexual function.
Asunto(s)
Cuello del Útero/anomalías , Crioterapia/métodos , Disfunciones Sexuales Fisiológicas/terapia , Disfunciones Sexuales Psicológicas/terapia , Enfermedades del Cuello del Útero/terapia , Adulto , Dispareunia/etiología , Dispareunia/terapia , Femenino , Humanos , Estudios Prospectivos , Calidad de Vida , Conducta Sexual/psicología , Disfunciones Sexuales Fisiológicas/etiología , Disfunciones Sexuales Psicológicas/etiología , Encuestas y Cuestionarios , Resultado del Tratamiento , Enfermedades del Cuello del Útero/complicaciones , Enfermedades del Cuello del Útero/psicologíaRESUMEN
A pseudoaneurysm of the uterine artery or its branches is usually a result of vascular trauma during invasive procedures such as a cesarean section, vaginal delivery, myomectomy, hysterotomy, or dilatation and curettage. A uterine artery pseudoaneurysm rupture is a rare, yet life-threatening event. Deep infiltrating endometriosis usually involves a decrease in symptoms and imaging findings throughout pregnancy, with the notable exception of the phenomenon of decidualization. We present the case of a pregnant woman with a recent diagnosis of endometriosis, who conceived spontaneously and presented with disabling pain at 13 weeks' gestation. She was diagnosed with a left, huge (and rapidly growing) retrocervical endometriosis nodule encompassing a uterine artery pseudoaneurysm. Selective transarterial embolization was performed at 22 weeks' gestation owing to enlargement of the pseudoaneurysm sac, and the pseudoaneurysm was obliterated successfully. The patient was followed intensively throughout the pregnancy and the baby was delivered at term by cesarean section. After delivery, the nodule returned to the pregestational size.
Asunto(s)
Aneurisma Falso/diagnóstico , Aneurisma Falso/etiología , Endometriosis/complicaciones , Enfermedades del Recto/complicaciones , Arteria Uterina/patología , Enfermedades del Cuello del Útero/complicaciones , Adulto , Aneurisma Falso/terapia , Cuello del Útero/patología , Endometriosis/diagnóstico , Endometriosis/terapia , Femenino , Humanos , Embarazo , Complicaciones Cardiovasculares del Embarazo/diagnóstico , Complicaciones Cardiovasculares del Embarazo/etiología , Complicaciones Cardiovasculares del Embarazo/terapia , Primer Trimestre del Embarazo , Enfermedades del Recto/diagnóstico , Enfermedades del Recto/terapia , Arteria Uterina/diagnóstico por imagen , Arteria Uterina/cirugía , Embolización de la Arteria Uterina , Enfermedades del Cuello del Útero/diagnóstico , Enfermedades del Cuello del Útero/terapiaRESUMEN
OBJECTIVE: Additional risk factors for preterm delivery in pregnant women with cervical shortening are not fully understood; however, mid-trimester cervical shortening is accepted as a risk factor for preterm delivery. This study aimed to identify risk factors associated with subsequent preterm delivery among patients with short cervix detected after late mid-trimester. MATERIALS AND METHODS: This was a retrospective study of medical data from a single perinatal tertiary facility. We identified 134 asymptomatic women with singleton pregnancies where cervical shortening (≤25 mm) was detected during routine universal screening at 22-33 weeks. Statistical analyses were conducted to identify causal relationships between the incidence of preterm delivery and known risk factors for preterm delivery. RESULTS: Incidence of preterm delivery was 27.6% (37/134) and preterm premature rupture of membrane was preceded in 46.0% (17/37) of the women with preterm delivery. Using logistic regression analysis, we identified uterine contractions [aOR 4.25, 95% confidence intervals (CI):1.68-12.1] and increased C-reactive protein (CRP) and increased white blood cell (WBC) in blood test (CRP: aOR 3.45, 95% CI:1.50-9.71; WBC: aOR 1.28, 95% CI: 1.08-1.55) as risk factors which significantly increased the risk of preterm delivery among women diagnosed with short cervix. Preterm delivery occurred in 91% of women positive for both uterine contractions and CRP >0.5 mg/dl. CONCLUSIONS: Uterine contraction and elevated CRP were additional risk factors for preterm delivery among women with short cervix. These results might be clinically useful to evaluate subsequent risk for preterm delivery in asymptomatic pregnant women presenting with short cervix in mid-pregnancy.
Asunto(s)
Segundo Trimestre del Embarazo/sangre , Nacimiento Prematuro/epidemiología , Enfermedades del Cuello del Útero/sangre , Enfermedades del Cuello del Útero/patología , Adulto , Proteína C-Reactiva/análisis , Medición de Longitud Cervical , Cuello del Útero/diagnóstico por imagen , Cuello del Útero/patología , Femenino , Rotura Prematura de Membranas Fetales/epidemiología , Rotura Prematura de Membranas Fetales/etiología , Humanos , Incidencia , Recuento de Leucocitos , Modelos Logísticos , Embarazo , Nacimiento Prematuro/etiología , Estudios Retrospectivos , Factores de Riesgo , Enfermedades del Cuello del Útero/complicaciones , Enfermedades del Cuello del Útero/diagnóstico por imagen , Contracción Uterina/sangreRESUMEN
Female genital tract tuberculosis (FGTB) is a chronic disease with varied presentation. The diagnosis of FGTB for early institution of treatment remains a clinical challenge. Its laboratory diagnosis is difficult because of paucibacillary nature of the condition and limitation of available diagnostic tests. In view of the intricate problems in diagnosis of FGTB, physicians tend to over treat with empirical anti-tuberculosis drugs. Apart from concerns of drug toxicity, this may be a contributing factor in the increasing incidence of multidrug-resistant TB reported in India. The main goal for advances in TB diagnostics is to reduce delay in diagnosis and treatment. In addition, there should be reduced complexity, improving robustness, and improving accuracy of the laboratory test for diagnosis of Female genital tuberculosis. OBJECTIVE: This narrative review is written with the following objectives. 1) To get a comprehensive overview as well as recent advances in diagnostic test used in the detection of FGTB. 2) To understand the limitations as well as advantages of these laboratory diagnostic test. 3) To provide clinical guidance regarding the detection in susceptible women. METHOD: The literature search was performed using electronic database of Pubmed, Medline, Embase and Google Scholar. Grey literature search was also done. Studies published in English were included. Following keywords were used for search - Tuberculosis, extra pulmonary tuberculosis, female genital tuberculosis, diagnosis of female genital tract tuberculosis. The personal knowledge and experience of authors in the field, helped in archiving the relevant articles. RESULT: Studies suggest that though culture is an invaluable contributor in the diagnosis of FGTB, molecular tests like PCR, LAMP, Xpert MTB/RIF and line probe assays have shown potential and are now being explored to strengthen the diagnostic algorithm of FGTB. CONCLUSION: The use of algorithm approach with combination of both rapid culture and newer molecular techniques will facilitate the accurate and timely diagnosis of FGTB.
Asunto(s)
Enfermedades de las Trompas Uterinas/diagnóstico , Enfermedades del Ovario/diagnóstico , Tuberculosis de los Genitales Femeninos/diagnóstico , Enfermedades del Cuello del Útero/diagnóstico , Enfermedades Uterinas/diagnóstico , Algoritmos , Antituberculosos/uso terapéutico , Infecciones Asintomáticas , Biopsia , Dolor Crónico/etiología , Dolor Crónico/fisiopatología , Técnicas de Cultivo , Endometrio/microbiología , Endometrio/patología , Enfermedades de las Trompas Uterinas/complicaciones , Enfermedades de las Trompas Uterinas/patología , Enfermedades de las Trompas Uterinas/fisiopatología , Femenino , Humanos , Histerosalpingografía , India , Infertilidad Femenina/etiología , Infertilidad Femenina/fisiopatología , Laparoscopía , Trastornos de la Menstruación/etiología , Trastornos de la Menstruación/fisiopatología , Técnicas de Diagnóstico Molecular , Técnicas de Amplificación de Ácido Nucleico , Enfermedades del Ovario/complicaciones , Enfermedades del Ovario/patología , Enfermedades del Ovario/fisiopatología , Dolor Pélvico/etiología , Dolor Pélvico/fisiopatología , Reacción en Cadena de la Polimerasa , Sensibilidad y Especificidad , Tuberculosis de los Genitales Femeninos/complicaciones , Tuberculosis de los Genitales Femeninos/patología , Tuberculosis de los Genitales Femeninos/fisiopatología , Enfermedades del Cuello del Útero/complicaciones , Enfermedades del Cuello del Útero/patología , Enfermedades del Cuello del Útero/fisiopatología , Enfermedades Uterinas/complicaciones , Enfermedades Uterinas/patología , Enfermedades Uterinas/fisiopatologíaRESUMEN
RATIONALE: Nabothian cysts are mucus-filled cervical cysts that are usually asymptomatic unless they become very large. Chronic urinary retention is the persistent inability to empty the bladder despite maintaining an ability to urinate. Chronic urinary retention caused by a large, deep nabothian cyst has not been reported previously. PATIENT CONCERNS: A 46-year-old woman presented with chronic urinary retention and a cervical cyst that gradually increased in size. DIAGNOSIS: Based on histopathological evidence, our patient was diagnosed with a nabothian cyst. INTERVENTIONS: A hysterectomy was performed. OUTCOMES: The urinary symptoms of the patient resolved after she performed clean, intermittent self-catheterizations for 5 days after the operation. She was discharged on postoperative day 6. LESSONS: Large nabothian cysts are rare but may account for some unusual symptoms including unexplained urinary difficulties in women. We recommend treating symptomatic nabothian cysts with local cystectomies or hysterectomies.
Asunto(s)
Quistes/complicaciones , Retención Urinaria/etiología , Enfermedades del Cuello del Útero/complicaciones , Quistes/diagnóstico por imagen , Quistes/cirugía , Femenino , Humanos , Histerectomía , Persona de Mediana Edad , Tomografía Computarizada por Rayos X , Enfermedades del Cuello del Útero/diagnóstico por imagen , Enfermedades del Cuello del Útero/cirugíaAsunto(s)
Divertículo/complicaciones , Leiomioma/patología , Enfermedades del Cuello del Útero/complicaciones , Neoplasias Uterinas/patología , Adulto , Divertículo/patología , Femenino , Humanos , Leiomioma/cirugía , Paridad , Enfermedades del Cuello del Útero/patología , Neoplasias Uterinas/cirugíaRESUMEN
Less than 10 deliveries via cervicovaginal fistula (CVF) with closed cervical os were reported so far. In the majority of cases, the patients had a history of induced abortions. The CVF was usually recognized due to postpartum hemorrhage. The facilitating role of prostaglandins used for labor induction was supposed. In all cases, the babies remained unaffected by the delivery route. We report a new case of a 37-year-old gravida 2, para 0, with a history of a paracervical tear following a first trimester abortion 11 years ago. The abortion and the laceration were not reported in the current obstetrical documentation. After labor induction using oral misoprostol in the 41 + 5 weeks of pregnancy, the patient delivered a healthy baby through a left-sided CVF, which imposed as bleeding paracervical laceration, 6 cm in diameter, extending to the vaginal fornix in the 3 o'clock position. The cervical os was only 1-1.5 cm dilated and imposed as an inelastic band ("squid ring") in the 9 o'clock position. The laceration was sutured under spinal anesthesia. The patient recovered quickly, and the postpartum hemoglobin drop was 2.8 g/dl. In conclusion, the possibility of CVF should be considered in women with a history of induced abortion.
Asunto(s)
Complicaciones del Trabajo de Parto/patología , Complicaciones del Embarazo/patología , Enfermedades del Cuello del Útero/patología , Fístula Vaginal/patología , Adulto , Femenino , Humanos , Recién Nacido , Trabajo de Parto Inducido/efectos adversos , Trabajo de Parto Inducido/métodos , Misoprostol/uso terapéutico , Complicaciones del Trabajo de Parto/etiología , Complicaciones del Trabajo de Parto/terapia , Embarazo , Complicaciones del Embarazo/terapia , Enfermedades del Cuello del Útero/complicaciones , Enfermedades del Cuello del Útero/terapia , Fístula Vaginal/complicaciones , Fístula Vaginal/terapiaRESUMEN
Background: Chlamydia trachomatis may coinfect with human papillomavirus (HPV) and complicate the cervical pathogenesis. This study aimed to evaluate the prevalence, risk factors, and clinical outcomes of HPV/C. trachomatis coinfection in women from Inner Mongolia, China. Methods: We performed a polymerase chain reaction (PCR)-based HPV/C. trachomatis screening and cervical samples were analyzed by thinprep cytologic test. Statistical analysis was used to assess the association between demographic factors and coinfection. Results: Among the 2345 women recruited, the prevalences of HPV, C. trachomatis, and HPV/C. trachomatis coinfection were 36.0%, 14.3%, and 4.8%, respectively. The rate of multiple HPV genotypes was higher in coinfected women. HPV66 was the most frequently identified genotype in coinfected participants. The HPV DNA load was significantly higher in HPV monoinfected cases. In contrast, the DNA load of C. trachomatis was significantly higher in the coinfection group. Risk factors, including single women (odds ratio [OR] = 6.0, 95% confidence interval [CI], 4.044-8.782) and women with multiple sex partners (OR = 1.9, 95% CI, 1.324-2.824), were associated with coinfection. Importantly, coinfection was associated with increased risk for high-grade squamous intraepithelial lesions. Conclusions: HPV and C. trachomatis coinfection is an important risk factor for the progression of cervical lesions.
Asunto(s)
Infecciones por Chlamydia/epidemiología , Infecciones por Chlamydia/virología , Chlamydia trachomatis/clasificación , Coinfección/epidemiología , Papillomaviridae/clasificación , Infecciones por Papillomavirus/epidemiología , Infecciones por Papillomavirus/virología , Adulto , Anciano , Anciano de 80 o más Años , Cuello del Útero/virología , China/epidemiología , Infecciones por Chlamydia/complicaciones , Chlamydia trachomatis/genética , Estudios de Cohortes , ADN Viral , Femenino , Genotipo , Humanos , Persona de Mediana Edad , Oportunidad Relativa , Papillomaviridae/genética , Infecciones por Papillomavirus/complicaciones , Prevalencia , Factores de Riesgo , Encuestas y Cuestionarios , Enfermedades del Cuello del Útero/complicaciones , Enfermedades del Cuello del Útero/epidemiología , Enfermedades del Cuello del Útero/virología , Adulto JovenAsunto(s)
Endometriosis/complicaciones , Hemorragia/etiología , Enfermedades del Cuello del Útero/complicaciones , Enfermedades Vaginales/etiología , Adulto , China , Endometriosis/diagnóstico , Endometriosis/patología , Femenino , Humanos , Imagen por Resonancia Magnética , Ultrasonografía , Enfermedades del Cuello del Útero/diagnóstico , Enfermedades del Cuello del Útero/patologíaRESUMEN
Cervical polyp is very rare in pregnancy, usually asymptomatic and small. There are several reports of different sizes of cervical polyp in pregnancy but, huge cervical polyp causing funnelling and shortening of cervical length was first reported in 2014. It was managed by polypectomy causing cervical length to return to normal value. We present the second case report in literature of a huge endocervical polyp in pregnancy that caused funnelling and shortening of cervical length. Unlike the earlier report this patient presented with preterm contractions and antepartum haemorrhage (APH). She was managed conservatively by polypectomy at 38 weeks of gestation without complications. This is the first case report in the literature of a huge symptomatic endocervical polyp in pregnancy presenting with preterm contractions and APH that was conservatively managed. The role of such management has been emphasized.
Asunto(s)
Cuello del Útero/patología , Pólipos/diagnóstico por imagen , Enfermedades del Cuello del Útero/diagnóstico por imagen , Adulto , Cuello del Útero/diagnóstico por imagen , Tratamiento Conservador , Femenino , Hemorragia/diagnóstico por imagen , Hemorragia/etiología , Humanos , Pólipos/complicaciones , Pólipos/cirugía , Embarazo , Complicaciones del Embarazo , Resultado del Embarazo , Resultado del Tratamiento , Enfermedades del Cuello del Útero/complicacionesRESUMEN
BACKGROUND: Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome has been considered as a childhood syndrome. The underlying etiology of PFAPA syndrome is unclear however, currently considered as auto-immune inflammatory disease. Recently, a few cases of adult-onset of PFAPA syndrome have been reported. However, there is no report about the successful management of pregnancy complicated with PFAPA syndrome. CASE PRESENTATION: The patient was a 31-year-old woman who developed recurrent episodes of high fever associated with cervical adenitis, pharyngitis and vomiting started 9 months after a delivery. She was diagnosed with PFAPA syndrome and cimetidine 800 mg/day was initiated. Since then, these symptoms got better. Cimetidine treatment was discontinued since she became pregnant (6 weeks of pregnancy). Except one febrile episode at 8 weeks gestation, she did not develop a febrile episode during pregnancy. Peripheral blood Th1/Th2 ratio was decreased from the first trimester to the second trimester of pregnancy. Then again, the ratio was steadily elevated during the third trimester. At 38 weeks, she delivered a live born infant without any complication. Two months after delivery, she developed PFAPA syndrome again and cimetidine treatment was re-initiated. However, febrile episodes were not controlled well, and Th1/Th2 ratio was further elevated compared to pregnancy status. Colchicine 0.5 mg once a day was initiated. Symptoms were diminished and Th1/Th2 ratio was gradually decreased. CONCLUSION: There was no case report of pregnancy complicated with PFAPA syndrome, though there were several reports of adult-onset PFAPA cases without pregnancy. The current case may be the first case report of a successful pregnancy complicated with PFAPA. In this case, PFAPA symptoms were ameliorated during pregnancy, but reappeared after delivery. We speculate that PFAPA syndrome, a Th1 type immune disorder, might be improved due to the Th1 to Th2 shifting, which was induced by pregnancy. It is necessary to investigate further about PFAPA syndrome with pregnancy and Th1/Th2 immune responses in the future.
Asunto(s)
Enfermedades Autoinflamatorias Hereditarias/complicaciones , Linfadenitis/complicaciones , Faringitis/complicaciones , Complicaciones del Embarazo , Estomatitis Aftosa/complicaciones , Enfermedades del Cuello del Útero/complicaciones , Adulto , Femenino , Humanos , Linfadenitis/congénito , Faringitis/congénito , Embarazo , Estomatitis Aftosa/congénito , Síndrome , Enfermedades del Cuello del Útero/congénitoRESUMEN
OBJECTIVES: Human papilloma virus (HPV) has been implicated in several types of epithelial cancer. The role of HPV in breast carcinogenesis has been a matter of debate fueled by conflicting reports in recent years. The aim of this study is to identify the prevalence of breast and cervical HPV infection in cancer patients by using a modern microarray approach. MATERIALS AND METHODS: In the present prospective study, 201 breast cancer patients were included. For each patient a detailed medical history was taken and during the operation, under sterile conditions, samples were collected, from the tumour, the healthy adjacent breast tissue and any positive sentinel lymph nodes. In addition, for each patient a cervical sample was also collected. All samples were analysed for DNA of 24 types of HPV using a microarray technique. RESULTS: Despite the high sensitivity of the technique used, no HPV DNA was identified in any of the breast or lymph node samples. Our analysis showed that patients with HPV positive cervical samples (28 cases) were more likely to have tumors with positive progesterone receptors (p=0.041) and were also more likely to have two or three positive lymph nodes (p=0.002). CONCLUSION: In the present study, a combination of careful sample collection and a very sensitive microarray approach showed no correlation between HPV and breast cancer. However some characteristics of the breast tumors were different among patients with HPV DNA in their cervical samples.
Asunto(s)
Neoplasias de la Mama/virología , Papillomaviridae/genética , Infecciones por Papillomavirus/complicaciones , Enfermedades del Cuello del Útero/virología , Adulto , Anciano , Mama/virología , Cuello del Útero/virología , ADN Viral/análisis , Femenino , Humanos , Ganglios Linfáticos/virología , Análisis por Micromatrices , Persona de Mediana Edad , Estudios Prospectivos , Enfermedades del Cuello del Útero/complicacionesAsunto(s)
Prolapso , Neuralgia del Pudendo/etiología , Enfermedades del Cuello del Útero/complicaciones , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Diafragma Pélvico , Pelvis , Neuralgia del Pudendo/diagnóstico por imagen , Neuralgia del Pudendo/rehabilitación , Enfermedades del Cuello del Útero/diagnóstico por imagenRESUMEN
BACKGROUND: The efficacy of vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix has been questioned after publication of the OPPTIMUM study. OBJECTIVE: To determine whether vaginal progesterone prevents preterm birth and improves perinatal outcomes in asymptomatic women with a singleton gestation and a midtrimester sonographic short cervix. STUDY DESIGN: We searched MEDLINE, EMBASE, LILACS, and CINAHL (from their inception to September 2017); Cochrane databases; bibliographies; and conference proceedings for randomized controlled trials comparing vaginal progesterone vs placebo/no treatment in women with a singleton gestation and a midtrimester sonographic cervical length ≤25 mm. This was a systematic review and meta-analysis of individual patient data. The primary outcome was preterm birth <33 weeks of gestation. Secondary outcomes included adverse perinatal outcomes and neurodevelopmental and health outcomes at 2 years of age. Individual patient data were analyzed using a 2-stage approach. Pooled relative risks with 95% confidence intervals were calculated. Quality of evidence was assessed using the GRADE methodology. RESULTS: Data were available from 974 women (498 allocated to vaginal progesterone, 476 allocated to placebo) with a cervical length ≤25 mm participating in 5 high-quality trials. Vaginal progesterone was associated with a significant reduction in the risk of preterm birth <33 weeks of gestation (relative risk, 0.62; 95% confidence interval, 0.47-0.81; P = .0006; high-quality evidence). Moreover, vaginal progesterone significantly decreased the risk of preterm birth <36, <35, <34, <32, <30, and <28 weeks of gestation; spontaneous preterm birth <33 and <34 weeks of gestation; respiratory distress syndrome; composite neonatal morbidity and mortality; birthweight <1500 and <2500 g; and admission to the neonatal intensive care unit (relative risks from 0.47-0.82; high-quality evidence for all). There were 7 (1.4%) neonatal deaths in the vaginal progesterone group and 15 (3.2%) in the placebo group (relative risk, 0.44; 95% confidence interval, 0.18-1.07; P = .07; low-quality evidence). Maternal adverse events, congenital anomalies, and adverse neurodevelopmental and health outcomes at 2 years of age did not differ between groups. CONCLUSION: Vaginal progesterone decreases the risk of preterm birth and improves perinatal outcomes in singleton gestations with a midtrimester sonographic short cervix, without any demonstrable deleterious effects on childhood neurodevelopment.
Asunto(s)
Nacimiento Prematuro/prevención & control , Progesterona/uso terapéutico , Progestinas/uso terapéutico , Enfermedades del Cuello del Útero/tratamiento farmacológico , Administración Intravaginal , Femenino , Humanos , Recién Nacido , Embarazo , Resultado del Embarazo , Nacimiento Prematuro/etiología , Riesgo , Resultado del Tratamiento , Enfermedades del Cuello del Útero/complicacionesRESUMEN
Angiomatosis of the uterus, cervix and fallopian tubes is a rare and benign entity that has not been reported in the literature previously. We present a case of a 27-year-old patient with severe and intractable heavy menstrual bleeding unresponsive to all conservative and conventional forms of treatment. Following a laparoscopic hysterectomy, the histopathological finding of angiomatosis, a vascular abnormality in the uterus, cervix and fallopian tubes, provided a plausible explanation in this situation.
Asunto(s)
Angiomatosis/complicaciones , Enfermedades de las Trompas Uterinas/complicaciones , Menorragia/etiología , Enfermedades del Cuello del Útero/complicaciones , Adulto , Angiomatosis/cirugía , Enfermedades de las Trompas Uterinas/cirugía , Femenino , Humanos , Histerectomía , Enfermedades del Cuello del Útero/cirugíaRESUMEN
BACKGROUND: Preterm birth is in quantity and in severity the most important topic in obstetric care in the developed world. Progestogens and cervical pessaries have been studied as potential preventive treatments with conflicting results. So far, no study has compared both treatments. METHODS/DESIGN: The Quadruple P study aims to compare the efficacy of vaginal progesterone and cervical pessary in the prevention of adverse perinatal outcome associated with preterm birth in asymptomatic women with a short cervix, in singleton and multiple pregnancies separately. It is a nationwide open-label multicentre randomized clinical trial (RCT) with a superiority design and will be accompanied by an economic analysis. Pregnant women undergoing the routine anomaly scan will be offered cervical length measurement between 18 and 22 weeks in a singleton and at 16-22 weeks in a multiple pregnancy. Women with a short cervix, defined as less than, or equal to 35 mm in a singleton and less than 38 mm in a multiple pregnancy, will be invited to participate in the study. Eligible women will be randomly allocated to receive either progesterone or a cervical pessary. Following randomization, the silicone cervical pessary will be placed during vaginal examination or 200 mg progesterone capsules will be daily self-administered vaginally. Both interventions will be continued until 36 weeks gestation or until delivery, whichever comes first. Primary outcome will be composite adverse perinatal outcome of perinatal mortality and perinatal morbidity including bronchopulmonary dysplasia, intraventricular haemorrhage grade III and IV, periventricular leukomalacia higher than grade I, necrotizing enterocolitis higher than stage I, Retinopathy of prematurity (ROP) or culture proven sepsis. These outcomes will be measured up until 10 weeks after the expected due date. Secondary outcomes will be, among others, time to delivery, preterm birth rate before 28, 32, 34 and 37 weeks, admission to neonatal intensive care unit, maternal morbidity, maternal admission days for threatened preterm labour and costs. DISCUSSION: This trial will provide evidence on whether vaginal progesterone or a cervical pessary is more effective in decreasing adverse perinatal outcome in both singletons and multiples. TRIAL REGISTRATION: Trial registration number: NTR 4414 . Date of registration January 29th 2014.
Asunto(s)
Cuello del Útero/patología , Pesarios , Nacimiento Prematuro/prevención & control , Progesterona/administración & dosificación , Progestinas/administración & dosificación , Enfermedades del Cuello del Útero/complicaciones , Administración Intravaginal , Adolescente , Adulto , Medición de Longitud Cervical , Protocolos Clínicos , Femenino , Humanos , Embarazo , Resultado del Embarazo , Nacimiento Prematuro/etiología , Resultado del Tratamiento , Enfermedades del Cuello del Útero/diagnóstico por imagen , Enfermedades del Cuello del Útero/patología , Adulto JovenRESUMEN
OBJECTIVE: To compare the efficacy of a double-balloon catheter versus vaginal prostaglandin E2 (dinoprostone) for cervical ripening in obese patients with unfavorable cervix at term. METHODS: The study had an open-label, prospective combined with retrospective, observational design. From January 2013 until May 2016, a prospective cohort study of 46 women with pre-pregnancy BMI>30kg/m2, live singleton term fetuses (>37 weeks) in vertex presentation and unfavorable cervix (Bishop score<6), who underwent labor induction for conventional indications using a double-balloon catheter. In the same period, 46 obese women who had undergone cervical ripening using vaginal dinoprostone (3mg) were retrospectively included. Women in groups were paired according to Bishop score before the insertion, pre-pregnancy BMI and parity. The primary outcome was a favorable cervix (Bishop score ≥6) 24h after cervical ripening. RESULTS: After 24h, there was a significantly higher rate of women with favorable cervix (Bishop score ≥6) in the double-balloon group than in dinoprostone group (80.4% vs 47.8%; P=0.001). After adjustment, a double-balloon catheter was significantly associated with an efficient cervical ripening compared to vaginal dinoprostone (aOR 7.81, 95% CI 2.58-23.60). No difference was observed in cesarean section rate (39.1% in each group; P=0.96) and in mean induction time to vaginal delivery (34.5h in the balloon group vs 36.5h in the dinoprostone group; P=0.53). Maternal and neonatal outcomes were similar. CONCLUSION: For obese patients at term, cervical ripening using a double-balloon catheter is more efficient on Bishop score after 24h compared to vaginal dinoprostone.
Asunto(s)
Cateterismo/métodos , Maduración Cervical/fisiología , Dinoprostona/administración & dosificación , Obesidad/complicaciones , Complicaciones del Embarazo/terapia , Administración Intravaginal , Adulto , Maduración Cervical/efectos de los fármacos , Femenino , Humanos , Trabajo de Parto Inducido/métodos , Oxitócicos/administración & dosificación , Embarazo , Estudios Prospectivos , Estudios Retrospectivos , Enfermedades del Cuello del Útero/complicaciones , Enfermedades del Cuello del Útero/terapiaRESUMEN
The authors describe a rare case of a giant nabothian cyst in a 52-year-old woman. The patient had a history of massive abnormal uterine bleeding after heavy physical work. A giant cystic mass, originating from the cervix, was found completely filling the upper third of the vagina. The authors combined hysteroscopy examination with ultrasound to assess the cystic mass' localization, origin, and relationship with other organs. With the tentative diagnosis of a giant nabothian cyst, the patient was treated with a simple cervical incision and local drainage. The patient recovered well postoperatively and the diagnosis was confirmed through pathological examination.